alexa Abstract | Breakthroughs of 2015-Personalized Immunotherapy Based on Individual GWAS and Biomarkers

Biomarkers Journal
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

We at Biomarkers Journal had opportunity to report “a clue of persoanlized immunotherapy” [1]. In the late 1980s, Rosenberg and his colleagues initially administered autologous T-cells to treat malignant melanoma (such as tumor-infiltrating lymphocyte, TIL). After that, TIL, nature killer cells, cytokine-induced peripheral blood mononuclear cells (lymphokine activated killer, LAK; cytokine-induced killer cells, CIK; dendritic cells and cytokineinduced killer cells, DC-CIK), and macrophage have been greatly developed into adoptive immunotherapy. Initially, TIL had some responses to treat tumor patients, however, the cells only achieved 11-30% partial and complete responses (PR and CR) as left photo.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Biaoru Li

Keywords

Biomarkers, Biological Markers, Biomarkers, Biological Markers

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords